High-throughput simultaneous analysis of five urinary metabolites of areca nut and tobacco alkaloids by isotope-dilution liquid chromatography-tandem mass spectrometry with on-line solid-phase extraction

Cancer Epidemiology Biomarkers and Prevention

Volumn 19, Issue 10, 2010, Pages 2570-2581

  Hu, Chiung Wen ^a,b   Chang, Yan Zin ^a   Wang, Hsiao Wen ^a   Chao, Mu Rong ^a  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

1 METHYLNIPECOTIC ACID; ARECAIDINE; ARECOLINE; COTININE; CREATININE; DEUTERIUM; NICOTINE; NICOTINIC AGENT; UNCLASSIFIED DRUG;

ACCURACY; ADULT; ARTICLE; BETEL NUT; HALF LIFE TIME; HUMAN; HUMAN EXPERIMENT; ISOTOPE DILUTION ASSAY; LIQUID CHROMATOGRAPHY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SMOKING; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; TOBACCO; URINE;

ADULT; ARECA; ARECOLINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COTININE; CROSS-SECTIONAL STUDIES; HUMANS; MALE; MIDDLE AGED; NICOTINE; SMOKING; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; TOBACCO; YOUNG ADULT;

EID: 77958065258     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-10-0483     Document Type: Article

References (40)

1. Winstock A. Areca nut-abuse liability, dependence and public health. Addict Biol 2002;7:133-8. (Pubitemid 34087917)
2. Gupta PC, Ray CS. Epidemiology of betel quid usage. Ann Acad Med 2004;33:31-6.
3. Nair U, Bartsch H, Nair J. Alert for an epidemic of oral cancer due to use of the betel quid substitutes gutkha and pan masala: a review of agents and causative mechanisms. Mutagenesis 2004;19:251-62.
4. International Agency for Research on Cancer. Tobacco habits other than smoking; betel-quid and areca-nut chewing; and some related nitrosamines. IARC monographs on the evaluation of carcinogenic risks to humans. Vol. 37. Lyon: IARC; 1985.
5. International Agency for Research on Cancer. Betel-quid and areca-nut chewing and some areca-nut-derived nitrosamines. IARC monographs on the evaluation of carcinogenic risks to humans. Vol. 85. Lyon: IARC; 2004.
6. Lord GA, Lim CK, Warnakulasuriya S, Peters TJ. Chemical and analytical aspects of areca nut. Addict Biol 2002;7:99-102.
7. Chu NS. Neurological aspects of areca and betel chewing. Addict Biol 2002;7:111-4.
8. Tsai YS, Lee KW, Huang JL, et al. Arecoline, a major alkaloid of areca nut, inhibits p53, represses DNA repair, and triggers DNA damage response in human epithelial cells. Toxicology 2008;249:230-7.
9. Giri S, Idle JR, Chen C, Zabriskie TM, Krausz KW, Gonzalez FJ. A metabolomic approach to the metabolism of the areca nut alkaloids arecoline and arecaidine in the mouse. Chem Res Toxicol 2006;19:818-27.
10. Proctor RN. The global smoking epidemic: a history and status report. Clin Lung Cancer 2004;5:371-6.
11. Hukkanen J, Jacob P III, Benowitz NL. Metabolism and disposition kinetics of nicotine. Pharmacol Rev 2005;57:79-115.
12. Matsuki H, Hashimoto K, Arashidani K, et al. Studies on a simultaneous analytical method of urinary nicotine and its metabolites, and their half-lives in urine. J UOEH 2008;30:235-52.
13. Heinrich J, Hölscher B, Seiwert M, Carty CL, Merkel G, Schulz C. Nicotine and cotinine in adults' urine: The German Environmental Survey 1998. J Expo Anal Environ Epidemiol 2005;15:74-80.
14. Petersen GO, Leite CE, Chatkin JM, Thiesen FV. Cotinine as a biomarker of tobacco exposure: development of a HPLC method and comparison of matrices. J Sep Sci 2010;33:516-21.
15. Hariharan M, VanNoord T. Liquid-chromatographic determination of nicotine and cotinine in urine from passive smokers: comparison with gas chromatography with a nitrogen-specific detector. Clin Chem 1991;37:1276-80.
16. Asthana S, Greig NH, Holloway HW, et al. Clinical pharmacokinetics of arecoline in subjects with Alzheimer's disease. Clin Pharmacol Ther 1996;60:276-82.
17. Hoofnagle AN, Laha TJ, Rainey PM, Sadrzadeh SM. Specific detection of anabasine, nicotine, and nicotine metabolites in urine by liquid chromatography-tandem mass spectrometry. Am J Clin Pathol 2006;126:880-7.
18. Pichini S, Pellegrini M, Pacifici R, et al. Quantification of arecoline (areca nut alkaloid) in neonatal biological matrices by high-performance liquid chromatography/electrospray quadrupole mass spectrometry. Rapid Commun Mass Spectrom 2003;17:1958-64.
19. Singh R, Farmer PB. Liquid chromatography-electrospray ionization-mass spectrometry: the future of DNA adduct detection. Carcinogenesis 2006;27:178-96.
20. Hu CW, Wang CJ, Chang LW, Chao MR. Clinical-scale high-throughput analysis of urinary 8-oxo-7,8-dihydro-2′-deoxyguanosine by isotopedilution liquid chromatography-tandem mass spectrometry with on-line solid-phase extraction. Clin Chem 2006;52:1381-8.
21. Hu CW, Chao MR, Sie CH. Urinary analysis of 8-oxo-7,8-dihydroguanine and 8-oxo-7,8-dihydro-2′-deoxyguanosine by isotope-dilution LC-MS/MS with automated solid-phase extraction: Study of 8-oxo-7,8-dihydroguanine stability. Free Radic Biol Med 2010;48:89-97.
22. Lee CH, Ko YC, Huang HL, et al. The precancer risk of betel quid chewing, tobacco use and alcohol consumption in oral leukoplakia and oral submucous fibrosis in southern Taiwan. Br J Cancer 2003;88:366-72.
23. Yang YD. Simultaneous determination of creatine, uric acid, creatinine and hippuric acid in urine by high performance liquid chromatography. Biomed Chromatogr 1998;12:47-9.
24. Wang S, Cyronak M, Yang E. Does a stable isotopically labeled internal standard always correct analyte response? A matrix effect study on a LC/MS/MS method for the determination of carvedilol enantiomers in human plasma. J Pharm Biomed Anal 2007;43:701-7.
25. Kim I, Huestis MA. A validated method for the determination of nicotine, cotinine, trans-3′-hydroxycotinine, and norcotinine in human plasma using solid-phase extraction and liquid chromatography-atmospheric pressure chemical ionization-mass spectrometry. J Mass Spectrom 2006;41:815-21.
26. Pellegrini M, Marchei E, Rossi S, et al. Liquid chromatography/ electrospray ionization tandem mass spectrometry assay for determination of nicotine and metabolites, caffeine and arecoline in breast milk. Rapid Commun Mass Spectrom 2007;21:2693-703.
27. Stokvis E, Rosing H, Beijnen JH. Stable isotopically labeled internal standards in quantitative bioanalysis using liquid chromatography/mass spectrometry: necessity or not? Rapid Commun Mass Spectrom 2005;19:401-7.
28. de Rooij BM, Boogaard PJ, Rijksen DA, Commandeur JN, Vermeulen NP. Urinaryexcretion of N-acetyl-S-allyl-L-cysteine upon garlic consumption by human volunteers. Arch Toxicol 1996;70:635-9.
29. Tuomi T, Johnsson T, Reijula K. Analysis of nicotine, 3-hydroxycotinine, cotinine, and caffeine in urine of passive smokers by HPLC-tandem mass spectrometry. Clin Chem 1999;45:2164-72.
30. Xu X, Iba MM, Weisel CP. Simultaneous and sensitive measurement of anabasine, nicotine, and nicotine metabolites in human urine by liquid chromatography-tandem mass spectrometry. Clin Chem 2004;50:2323-30.
31. Heavner DL, Richardson JD, Morgan WT, Ogden MW. Validation and application of a method for the determination of nicotine and five major metabolites in smokers' urine by solid-phase extraction and liquid chromatography-tandem mass spectrometry. Biomed Chromatogr 2005;19:312-28.
32. Zhu MM, Chen HX, Han FM, Chen Y. Analysis of arecoline in rat urine, and. identification of its metabolites by liquid chromatography-tandem mass spectrometry. Chromatographia 2006;64:705-8.
33. Nery R. The metabolic interconversion of arecoline and arecoline 1-oxide in the rat. Biochem J 1971;122:503-8.
34. Giri S, Krausz KW, Idle JR, Gonzalez FJ. The metabolomics of (+/-)-arecoline 1-oxide in the mouse and its formation by human flavin-containing monooxygenases. Biochem Pharmacol 2007;73:561-73.
35. De Weerd S, Thomas CM, Kuster JE, Cikot RJ, Steegers EA. Variation of serum and urine cotinine in passive and active smokers and applicability in preconceptional smoking cessation counseling. Environ Res 2002;90:119-24.
36. Lu Y, Morimoto K. Exposure level to cigarette tar or nicotine is associated with leukocyte DNA damage in male Japanese smokers. Mutagenesis 2008;23:451-5.
37. Wang CK, Lee WH, Peng CH. Contents of phenolics and alkaloids in Areca. catechu Linn. during maturation. J Agric Food Chem 1997;45:1185-8.
38. Benowitz NL, Jacob P III, Kozlowski LT, Yu L. Influence of smoking fewer cigarettes on exposure to tar, nicotine, and carbon monoxide. N Engl J Med 1986;315:1310-3. (Pubitemid 17030407)
39. Scherer G. Smoking behaviour and compensation: a review of the literature. Psychopharmacology (Berl) 1999;145:1-20.
40. Ko YC, Huang YL, Lee CH, Chen MJ, Lin LM, Tsai CC. Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan. J Oral Pathol Med 1995;24:450-3.